Ignite Creation Date:
2024-05-06 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05157542
Status:
UNKNOWN
Last Update Posted:
2021-12-15
First Post:
2021-05-24
Brief Title:
Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC
Sponsor:
Juan LI MD
Organization:
Sichuan Cancer Hospital and Research Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage III Non-small Cell Lung Cancer |
Keywords: